LogicBio Therapeutics Receives FDA Fast Track Designation for LB-001 for the Treatment of Methylmalonic Acidemia (MMA)GlobeNewsWire • 11/04/20
LogicBio Therapeutics Announces Appointment of Veteran Biotech Executive Mariana Nacht, Ph.D., as Chief Scientific Officer and Kyle Chiang, Ph.D.GlobeNewsWire • 11/03/20
Fusion Pharmaceuticals Announces Collaboration with AstraZeneca to Develop and Commercialize Next-Generation Radiopharmaceuticals and Combination TherapiesPRNewsWire • 11/02/20
Regulators are accelerating reviews of COVID-19 vaccines from Pfizer and AstraZeneca, according to a reportMarket Watch • 10/30/20
Arcus to Collaborate With AstraZeneca on Registrational Trial for Domvanalimab, Arcus's Novel Anti-TIGIT Antibody, Plus Imfinzi® in Stage III NSCLCBusiness Wire • 10/29/20
AstraZeneca and J&J Resume Late-Stage Trials: How It Shakes Up the Coronavirus Vaccine RaceThe Motley Fool • 10/28/20
Investors Betting on a Coronavirus Vaccine Better Know Who Gets First Dibs in Global PactThe Motley Fool • 10/27/20
Covid Roundup: AstraZeneca Reports Positive Covid-19 Vaccine Data; Moderna Inks New Supply DealInvestors Business Daily • 10/26/20
Oxford-AstraZeneca coronavirus vaccine reportedly triggers immune response among adultsCNBC • 10/26/20
What Are the Differences Between the Leading Coronavirus Vaccine Candidates?The Motley Fool • 10/25/20
AstraZeneca says its Oxford vaccine deal allows it to add up to 20% of manufacturing costsReuters • 10/23/20